148 related articles for article (PubMed ID: 26139354)
1. Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
Martini T; Aziz A; Roghmann F; Rink M; Chun FK; Fisch M; Trojan L; Hakenberg OW; Zastrow S; Wirth MP; Moersdorf J; Brookman-May S; Stief CG; Haferkamp A; Wagenlehner F; Hohenfellner M; Herrmann E; Lusuardi L; Grimm MO; Müller SC; Roigas J; Bastian PJ; Gierth M; Burger M; Pycha A; Seitz C; May M; Bolenz C
Urol Int; 2016; 96(1):57-64. PubMed ID: 26139354
[TBL] [Abstract][Full Text] [Related]
2. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
[TBL] [Abstract][Full Text] [Related]
3. [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?].
May M; Burger M; Brookman-May S; Otto W; Peter J; Rud O; Fritsche HM; Bolenz C; Trojan L; Herrmann E; Michel MS; Wülfing C; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Bretschneider-Ehrenberg P; Müller O; Zacharias M; Gunia S; Bastian PJ
Urologe A; 2011 Jun; 50(6):706-13. PubMed ID: 21340594
[TBL] [Abstract][Full Text] [Related]
4. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
5. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I; Hofbauer SL; Leitner CV; de Martino M; Özsoy M; Susani M; Shariat SF; Klatte T
Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373
[TBL] [Abstract][Full Text] [Related]
6. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.
Aziz A; May M; Burger M; Palisaar RJ; Trinh QD; Fritsche HM; Rink M; Chun F; Martini T; Bolenz C; Mayr R; Pycha A; Nuhn P; Stief C; Novotny V; Wirth M; Seitz C; Noldus J; Gilfrich C; Shariat SF; Brookman-May S; Bastian PJ; Denzinger S; Gierth M; Roghmann F;
Eur Urol; 2014 Jul; 66(1):156-63. PubMed ID: 24388438
[TBL] [Abstract][Full Text] [Related]
7. Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.
Breyer J; Denzinger S; Otto W; Bründl J; Gierth M; Fritsche HM; Rößler W; Wieland WF; Giedl C; Hofstädter F; Rubenwolf P; Burger M; Aziz A
Urol Int; 2014; 93(3):311-9. PubMed ID: 25196313
[TBL] [Abstract][Full Text] [Related]
8. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
[TBL] [Abstract][Full Text] [Related]
9. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
May M; Bastian PJ; Brookman-May S; Burger M; Bolenz C; Trojan L; Michel MS; Herrmann E; Wülfing C; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Gilfrich C; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Gunia S; Fritsche HM
Scand J Urol Nephrol; 2011 Sep; 45(4):251-7. PubMed ID: 21388337
[TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer.
Schuettfort VM; Pradere B; Trinh QD; D'Andrea D; Quhal F; Mostafaei H; Laukhtina E; Mori K; Sari Motlagh R; Rink M; Karakiewicz PI; Chlosta P; Yuen-Chun Teoh J; Lotan Y; Scherr D; Abufaraj M; Moschini M; Shariat SF
Cancer Immunol Immunother; 2022 Jan; 71(1):85-95. PubMed ID: 34023914
[TBL] [Abstract][Full Text] [Related]
11. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.
Potretzke A; Hillman L; Wong K; Shi F; Brower R; Mai S; Cetnar JP; Abel EJ; Downs TM
Urol Oncol; 2014 Jul; 32(5):631-6. PubMed ID: 24629498
[TBL] [Abstract][Full Text] [Related]
12. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
Kim HS; Kwak C; Kim HH; Ku JH
Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
[TBL] [Abstract][Full Text] [Related]
13. Precystectomy nomogram for prediction of advanced bladder cancer stage.
Karakiewicz PI; Shariat SF; Palapattu GS; Perrotte P; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg M; Lerner SP
Eur Urol; 2006 Dec; 50(6):1254-60; discussion 1261-2. PubMed ID: 16831511
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
16. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
Fritsche HM; May M; Denzinger S; Otto W; Siegert S; Giedl C; Giedl J; Eder F; Agaimy A; Novotny V; Wirth M; Stief C; Brookman-May S; Hofstädter F; Gierth M; Aziz A; Kocot A; Riedmiller H; Bastian PJ; Toma M; Wieland WF; Hartmann A; Burger M
Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
Novotny V; Froehner M; May M; Protzel C; Hergenröther K; Rink M; Chun FK; Fisch M; Roghmann F; Palisaar RJ; Noldus J; Gierth M; Fritsche HM; Burger M; Sikic D; Keck B; Wullich B; Nuhn P; Buchner A; Stief CG; Vallo S; Bartsch G; Haferkamp A; Bastian PJ; Hakenberg OW; Propping S; Aziz A
World J Urol; 2015 Nov; 33(11):1753-61. PubMed ID: 25663359
[TBL] [Abstract][Full Text] [Related]
20. The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Burger M; Martini T; Pycha A; Dechet C; Lodde M; Comploj E; Wieland WF; Denzinger S; Otto W; Aziz A; Fritsche HM; Gierth M
Urol Int; 2014; 93(3):303-10. PubMed ID: 25139069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
